Apo-Amisulpride New Zealand - English - Medsafe (Medicines Safety Authority)

apo-amisulpride

apotex nz ltd - amisulpride 50mg;   - tablet - 50 mg - active: amisulpride 50mg   excipient: lactose monohydrate magnesium stearate methylcellulose microcrystalline cellulose sodium starch glycolate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

SOLIAN 100 amisulpride 100 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

solian 100 amisulpride 100 mg tablet blister pack

sanofi-aventis australia pty ltd - amisulpride, quantity: 100 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate type a; lactose monohydrate; hypromellose; magnesium stearate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

SOLIAN 100MG/ML ORAL SOLUTION 100 Mg/Ml Oral Solution Ireland - English - HPRA (Health Products Regulatory Authority)

solian 100mg/ml oral solution 100 mg/ml oral solution

sanofi-aventis ireland limited t/a sanofi - amisulpride - oral solution - 100 mg/ml

Sulprix New Zealand - English - Medsafe (Medicines Safety Authority)

sulprix

viatris limited - amisulpride 100mg;   - tablet - 100 mg - active: amisulpride 100mg   excipient: hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

SULPRIX amisulpride 100 mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sulprix amisulpride 100 mg tablets blister pack

alphapharm pty ltd - amisulpride, quantity: 100 mg - tablet - excipient ingredients: magnesium stearate; lactose monohydrate; microcrystalline cellulose; hypromellose; sodium starch glycollate type a - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.